The Reserve Bank of India has introduced a comprehensive framework mandating the use of a Unique Transaction Identifier (UTI) for over-the-counter (OTC) derivative transactions. The UTI is a globally recognised data element intended to enhance transparency and enable policymakers to obtain a holistic view of the OTC derivatives market. By standardising transaction identification, the measure aims to strengthen market surveillance, risk monitoring, and regulatory reporting.
Currently, transactions in OTC markets—covering Rupee interest rate derivatives, forward contracts in Government securities, foreign currency derivatives, foreign currency interest rate derivatives, and credit derivatives—are reported to the Trade Repository managed by the Clearing Corporation of India Limited (CCIL-TR). The new directions make it mandatory for all such transactions to carry a UTI. The framework will come into effect from January 1, 2027, and will apply to OTC derivative contracts entered into on or after that date. These directions have been issued under the powers conferred by Sections 45W and 45U of the RBI Act, 1934.
The requirement applies to OTC derivative transactions governed by various regulatory frameworks, including foreign exchange derivative regulations, the Rupee Interest Rate Derivatives Directions, Forward Contracts in Government Securities Directions, and the Credit Derivatives Directions, along with any other directions specified by the Reserve Bank.
Under the framework, the UTI must be generated in line with the technical guidance issued by the Committee on Payments and Market Infrastructures and the International Organization of Securities Commissions in February 2017. The identifier can have up to 52 characters and must include the Legal Entity Identifier (LEI) of the generating entity, followed by a unique transaction-specific component. Importantly, the UTI must remain constant throughout the lifecycle of the derivative contract.
Responsibility for generating the UTI follows a prescribed waterfall approach. Depending on the transaction structure, the central counterparty (CCP), electronic trading platform (ETP), clearing member, or a mutually agreed counterparty may generate the UTI. If the transaction is reported to CCIL-TR without a UTI, the repository will generate one. Special provisions apply where transactions are reportable in both India and foreign jurisdictions, particularly when overseas reporting timelines are earlier.
The framework clarifies that routine amendments to a reported derivative contract do not require a new UTI. However, lifecycle events such as novation that create a new reportable contract will necessitate generation of a fresh UTI. CCIL will issue detailed operating guidelines and reporting formats, and market participants are required to establish systems and processes to ensure full compliance with the new directions.
